Skip to main content
SpringerLink
Log in

Domperidone in pregnancy: congenital anomalies or natural terminations

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Evaluation chez la Femme Enceinte des MEdicaments et de leurs RISques

Reference

  • Vabre C, et al. Risk of Pregnancy Termination and Congenital Anomalies After Domperidone Exposure: A Study in the EFEMERIS Database. Drug Safety : 10 May 2021. Available from: URL: https://doi.org/10.1007/s40264-021-01077-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Domperidone in pregnancy: congenital anomalies or natural terminations. Reactions Weekly 1856, 9 (2021). https://doi.org/10.1007/s40278-021-96002-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-96002-7

Search

Navigation